作为建议事项的一部分，彩客科技将配发彩客科技股份，此举将减少集团于彩客科技的股权比例。有关 配发(倘落实)将构成上市规则第14.29条项下视作出售集团附属公司权益。 公告称，彩客科技股份自2022年8月起于全国股转挂牌。公司认为，通过将彩客科技股份从全国股转转 板至北京证券交易所上市，将使股份目前于全国股转挂牌的彩客科技获得上市公司的地位，这将使彩客 科技能够：(a)凭借北京证券交易所更广的投资者范围及更高的交易量，增强彩客科技股份的交易活跃 度及流动性，并反映彩客科技的公允价值以为股东带来收益;(b)提升彩客科技的企业形象及声誉，并提 高彩客科技吸引能与其产生协同效应的战略投资者的能力;(c)提升彩客科技的资本市场融资效率，增强 其企业管治并加快其企业发展;及(d)进一步改善公司的财务结构，降低公司的资产负债率，增强公司的 资本实力，从而为公司的业务发展作出贡献。 此外，彩客科技拟将建议事项所得款项用于将增强其颜料中间体及新材料产品(即DMS、DMSS、DATA 及BPDA)产能的项目。通过实施上述项目，彩客科技可增强其竞争优势，并最终增加其市场份额及提升 其盈利能力。流动资金及产能增加的综合效益促进收入及 ...

Core Viewpoint - The company has entered into an exclusive licensing agreement with Alvogen Korea for the commercialization of its innovative anti-PD-1 monoclonal antibody, Hanshuo® (sulizumab injection), in South Korea [1][2]. Group 1: Product Information - Hanshuo® is an innovative anti-PD-1 monoclonal antibody developed by the company, approved for various indications in mainland China, including squamous non-small cell lung cancer (sqNSCLC), extensive small cell lung cancer (ES-SCLC), esophageal squamous cell carcinoma (ESCC), and non-squamous non-small cell lung cancer (nsNSCLC) [2]. - The product has also received approvals in the European Union, Indonesia, Cambodia, and Thailand, and has been granted orphan drug designation by the FDA and the European Commission for small cell lung cancer [2]. Group 2: Market Potential - According to IQVIA MIDAS TM, the global sales of anti-PD-1 monoclonal antibodies are projected to reach approximately $45.55 billion in 2024 [3]. - The collaboration with Alvogen Korea is expected to enhance the company's product accessibility and recognition in international markets, contributing to sustained revenue growth [3]. Group 3: Commercialization Strategy - The company leads the sales and promotion of Hanshuo® in mainland China through its own commercialization team and has established partnerships for commercialization in Europe, India, Southeast Asia, the Middle East, North Africa, and the United States [3].

Group 1 - RoboSense CEO Qiu Chunchao attended the SAIC Volkswagen Brand Day event during the Shanghai Auto Show on April 25, 2025 [1] - A strategic cooperation agreement was signed between SAIC Volkswagen and representatives from companies including Baidu, Alibaba Cloud, and CATL [1]

Summary of Key Points Core Viewpoint - The Hong Kong stock market experienced significant net selling from northbound capital, totaling 70.19 billion HKD, with notable net selling in major stocks like Tencent and Alibaba, while Meituan and Sunac China saw net buying [1][2]. Group 1: Northbound Capital Flow - Northbound capital recorded a net selling of 70.19 billion HKD, with 21.59 billion HKD from the Shanghai Stock Connect and 48.61 billion HKD from the Shenzhen Stock Connect [1]. - The stocks with the highest net buying included Meituan (03690), Sunac China (01918), and Chifeng Jilong Gold Mining (06693) [1]. - The stocks with the highest net selling included Tencent (00700), Alibaba (09988), and China Mobile (00941) [1]. Group 2: Individual Stock Performance - Meituan (03690) received a net buying of 7.45 billion HKD, supported by a report from Citigroup indicating no risk of ADR delisting and stable business income [4]. - Sunac China (01918) saw a net buying of 1.69 billion HKD, as the company is actively seeking support for its debt restructuring plan, with significant progress reported [5]. - Chifeng Jilong Gold Mining (06693) achieved a net buying of 221.9 million HKD, reporting a 29.85% increase in revenue and a 141.10% increase in net profit year-on-year [5]. Group 3: Sector-Specific Trends - Semiconductor stocks like Hua Hong Semiconductor (01347) and SMIC (00981) faced net selling of 1.79 billion HKD and 5 billion HKD, respectively, amid changes in import tariffs for certain semiconductor products [6]. - China National Offshore Oil Corporation (00883) experienced a net selling of 2.81 billion HKD, influenced by OPEC+ countries' discussions on increasing production [6]. - China Mobile (00941) had a net selling of 5.09 billion HKD, with a slight revenue growth of 0.02% in Q1, indicating a slowdown in the telecom sector [7].

Core Viewpoint - The company has entered into a licensing agreement with Alvogen Korea Co., Ltd. for the exclusive commercialization of Hansizhuang (Sruvul monoclonal antibody injection) in South Korea [1] Financial Terms - Alvogen Korea will pay an upfront fee of $5 million [1] - Regulatory milestone payments will not exceed $9.5 million [1] - Commercial sales milestone payments will not exceed $97.5 million [1] - Tiered royalties based on annual net sales will range from 18% to 25% [1] Agreement Duration - The licensing agreement is effective from the date of signing and will remain valid for 10 years from the date of the first commercial sale of the licensed product [1]

智通财经APP讯，望尘科技控股(02458)发布公告，根据授出，董事会已议决根据股东于2024年股东周年 大会上授出的一般授权向独立受托人发行合共474.29万股新股份(股份发行)，据此，本公司将获准配 发、发行及处理最多2760万股股份，以于2024年7月11日根据2023年股份奖励计划向61名雇员参与者(承 授人)授出474.29万股奖励股份。根据2023年股份奖励计划授出奖励(将透过在计划授权限额内发行新股 份结算)的原因为表彰及奖励承授人对本集团增长及发展的贡献，并给予奖励，以挽留彼等为本集团的 持续营运及发展作贡献。股份发行毋须取得股东进一步批准。除股份发行外，于本公告日期，概无根据 上述一般授权发行或配发新股份。 根据2023年股份奖励计划，董事会将支付发行新股份的认购款项4.74万港元，即股份面值乘以将予发行 的股份数目，自本公司的内部资源拨资。独立受托人须以现金认购新股份，而该等新股份将于各情况下 达成指定归属条件后免费转让予承授人。 本公司将发行及配发予独立受托人以支付上述授出474.29万股奖励股份的新股份，占本公告日期本公司 已发行股份(不包括库存股份)约3.4377%及本公司于有关发行 ...

Group 1 - Southbound funds recorded a net sell of 70.19 billion HKD today [1] - Tencent Holdings faced the highest net sell at 14.89 billion HKD [1] - Alibaba-W also experienced significant net selling of 8.95 billion HKD [1] Group 2 - Meituan-W saw a net buy of 7.45 billion HKD [1]

Group 1 - Southbound funds experienced a significant net sell-off of 70.19 billion yuan today [1] - In the Hong Kong Stock Connect (Shanghai), Tencent Holdings and Alibaba-W saw net sell-offs of 9.12 million HKD and 7.22 million HKD respectively [1] - Meituan-W had the highest net buy amount at 4.68 million HKD in the Hong Kong Stock Connect (Shanghai) [1] Group 2 - In the Hong Kong Stock Connect (Shenzhen), Tencent Holdings and Pop Mart experienced net sell-offs of 5.77 million HKD and 5.06 million HKD respectively [1] - Meituan-W again led with the highest net buy amount at 2.77 million HKD in the Hong Kong Stock Connect (Shenzhen) [1]

今年《哪吒2》的爆火，带飞了联名的国产卡牌，也让卡游这家"卖卡牌"的公司出了圈。 从当初的奥特曼到去年的小马宝莉，再到今年的哪吒系列卡牌，卡游正从昔日的中小学生"心头好"，向更广阔的消费圈层突破。日前，作为集换式卡牌行 业唯一的龙头，它正式向港股发起了冲刺。 依靠售价2元一包的小小卡牌，卡游成了"IP印钞机"。在2024年，公司突破百亿元营收大关，经调整净利润达到44.66亿元，综合毛利率高达67.3%，甚至 超过了泡泡玛特，堪称国内赚钱能力最强的一家玩具公司。 创办卡游的浙江衢州大佬李奇斌，今年已经53岁。在卡游提交招股书前，他2024年从公司领走了18亿元的天价薪酬。一旦卡游成功上市，李奇斌的身家， 也将迎来暴涨。 市场上最会赚钱的玩具公司 "刚看完《哪吒2》电影时，我抽卡上头了。"一位年轻白领小吕说。尽管自己是成年人，但对这个IP的喜爱，仍然让她忍不住下单。整个2月，她在直播间 里陆续花费了近1万元。"或许等热度过了，它们就不过是一张纸片。但至少在那时，我是真心因为里面的角色喜欢它"。 当哪吒联名卡牌成为现象级产品时，原本小众的国产卡牌行业以及卡游这家公司，也在大众视野内露出头角。 卡游两次递交的招股说 ...

Group 1 - The company, Fosun International, announced an increase in its stake in the non-listed shares of Fuhong Hanlin, with a deadline set for April 21, 2025 [1] - In previous announcements, Ms. Tseng Chi-Ling was identified as the largest single shareholder of HenLink, holding 27.69% of its shares [1] - Mr. Liu Hsing-Jin and Mr. Ho Tung-Kuang hold 26.60% and 11.89% of HenLink's shares, respectively [1]